KBC Group
TWST icon

KBC Group’s Twist Bioscience TWST Stock Holding History

KBC Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101K Hold
2,121
– – ﹤0.01% 1318
2025
Q4 		$67K Hold
2,121
– – ﹤0.01% 1524
2025
Q3 		$60K Hold
2,121
– – ﹤0.01% 1582
2025
Q2 		$78K Sell
2,121
-985
-32% -$34K ﹤0.01% 1369
2025
Q1 		$122K Buy
3,106
+164
+6% +$7.39K ﹤0.01% 1370
2024
Q4 		$137K Buy
2,942
+1,226
+71% +$55.4K ﹤0.01% 1353
2024
Q3 		$78K Hold
1,716
– – ﹤0.01% 1454
2024
Q2 		$85K Hold
1,716
– – ﹤0.01% 1267
2024
Q1 		$59K Buy
1,716
+570
+50% +$20.6K ﹤0.01% 1454
2023
Q4 		$42K Hold
1,146
– – ﹤0.01% 1655
2023
Q3 		$23K Buy
+1,146
New +$25.2K ﹤0.01% 1866

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KBC Group's TWST Position: Q1 2026 in Review

KBC Group held its Twist Bioscience (TWST) position steady in Q1 2026 at 2,121 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

KBC Group first reported a position in TWST in Q3 2023 and has held it in 11 quarters since. The position peaked at $137K in Q4 2024. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • KBC Group held 2,121 shares of Twist Bioscience worth $101K as of Q1 2026.
  • KBC Group left its Twist Bioscience share count unchanged in Q1 2026.
  • Twist Bioscience made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1318 holding.
  • KBC Group first reported a position in Twist Bioscience in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Twist Bioscience position peaked at $137K in Q4 2024.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.